Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Kira8 (AMG-18) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity (IC50: 5.9 nM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 20,500 | |||
5 mg | 在庫あり | ¥ 49,000 | |||
10 mg | 在庫あり | ¥ 74,000 | |||
25 mg | 在庫あり | ¥ 137,000 | |||
50 mg | 在庫あり | ¥ 195,500 | |||
100 mg | 在庫あり | ¥ 268,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 65,000 |
説明 | Kira8 (AMG-18) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity (IC50: 5.9 nM). |
ターゲット&IC50 | IRE1α:5.9 nM(IRE1α RNase) |
In vitro | Kira8 more effectively causes IRE1α-driven apoptosis in INS-1 cells than KIRA6 and also reverses XBP1 splicing promoted by GNF-2. Kira8 blocks IRE1α oligomerization and effectively inhibits IRE1α RNase activity against XBP1 and Ins2 RNAs. |
In vivo | One week of treatment of pre-diabetic NODs mice with Kira8 (50 mg/kg; i.p.; once a day) causes obvious reductions in islet XBP1 splicing and TXNIP mRNAs. It also preserves Ins1/Ins2, BiP, and MANF mRNAs. Male Ins2+/Akita mice are injected i.p. with KIRA8 (50 mg/kg; daily; for 35 days), obviously reduction of hyperglycemia becomes apparent over several weeks. |
別名 | AMG-18 |
分子量 | 601.12 |
分子式 | C31H29ClN6O3S |
CAS No. | 1630086-20-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/mL (108.13 mM), Sonication is recommended.
H2O: insoluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Kira8 1630086-20-2 Cell Cycle/Checkpoint IRE1 Inositol requiring enzyme 1 inhibit AMG-18 Kira 8 Inhibitor Kira-8 AMG 18 AMG18 inhibitor